GeneDx Holdings Corp.WGSNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank67
3Y CAGR-21.9%
5Y CAGR+4.4%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-21.9%/yr
Annual compound
5Y CAGR
+4.4%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$305.39M+40.3%
2024$217.61M-19.6%
2023$270.60M-57.8%
2022$640.90M+49.2%
2021$429.55M+74.6%
2020$246.02M+117.3%
2019$113.20M-